123 related articles for article (PubMed ID: 37172479)
1. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract][Full Text] [Related]
2. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
5. Ginkgetin Blocks Constitutive STAT3 Activation and Induces Apoptosis through Induction of SHP-1 and PTEN Tyrosine Phosphatases.
Baek SH; Lee JH; Ko JH; Lee H; Nam D; Lee SG; Yang WM; Um JY; Lee J; Kim SH; Shim BS; Ahn KS
Phytother Res; 2016 Apr; 30(4):567-76. PubMed ID: 27059688
[TBL] [Abstract][Full Text] [Related]
6. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
7. Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3/JAK2/SIRT1.
Xu B; He X; Sui Y; Wang X; Wang X; Ren L; Zhai YX
Folia Neuropathol; 2019; 57(1):16-23. PubMed ID: 31038184
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
[TBL] [Abstract][Full Text] [Related]
9. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis.
Liu Q; Chen L; Yin W; Nie Y; Zeng P; Yang X
Cell Cycle; 2022 Jan; 21(1):74-85. PubMed ID: 34878966
[TBL] [Abstract][Full Text] [Related]
11. Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway.
Pan LL; Wu WJ; Zheng GF; Han XY; He JS; Cai Z
Z Naturforsch C J Biosci; 2017 Oct; 72(11-12):441-447. PubMed ID: 28902633
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo.
Kandala PK; Srivastava SK
Drug Discov Ther; 2012 Apr; 6(2):94-101. PubMed ID: 22622019
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS.
Liang JR; Yang H
Biomed Pharmacother; 2020 May; 125():109585. PubMed ID: 32106377
[TBL] [Abstract][Full Text] [Related]
14. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
[TBL] [Abstract][Full Text] [Related]
15. Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.
Xu P; Wang H; Pan H; Chen J; Deng C
Cancer Chemother Pharmacol; 2022 Feb; 89(2):183-196. PubMed ID: 34997858
[TBL] [Abstract][Full Text] [Related]
16. Ginkgetin exerts growth inhibitory and apoptotic effects on osteosarcoma cells through inhibition of STAT3 and activation of caspase-3/9.
Xiong M; Wang L; Yu HL; Han H; Mao D; Chen J; Zeng Y; He N; Liu ZG; Wang ZY; Xu SJ; Guo LY; Wang YA
Oncol Rep; 2016 Feb; 35(2):1034-40. PubMed ID: 26573608
[TBL] [Abstract][Full Text] [Related]
17. Ginkgetin induces apoptosis in 786-O cell line
Ren Y; Huang SS; Wang X; Lou ZG; Yao XP; Weng GB
Iran J Basic Med Sci; 2016 Nov; 19(11):1245-1250. PubMed ID: 27917282
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
[TBL] [Abstract][Full Text] [Related]
19. Effects of Ginkgetin from Ginkgo biloba Leaves on cyclooxygenases and in vivo skin inflammation.
Kwak WJ; Han CK; Son KH; Chang HW; Kang SS; Park BK; Kim HP
Planta Med; 2002 Apr; 68(4):316-21. PubMed ID: 11988854
[TBL] [Abstract][Full Text] [Related]
20. Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/STAT3 signal pathway.
Shi X; Lai Y; Liu W; Zhang X; Cang Y
Biochem Biophys Res Commun; 2024 Apr; 706():149758. PubMed ID: 38484571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
